Capital International, Inc. Astrazeneca PLC Transaction History

Capital International, Inc.

$7.11 Billion
Q1 2024

A detailed history of Capital International, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Capital International, Inc. holds 238,030 shares of AZN stock, worth $18.7 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

238,030

Previous 202,572 17.5%

Holding current value

$18.7 Million

Previous $13.6 Million 18.2%

% of portfolio

0.23%

Previous 0.22%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$61.03 - $69.57 $2.16 Million - $2.47 Million	35,458 Added 17.5%	238,030 $16.1 Million
Q4 2023 Feb 13, 2024	BUY	$61.89 - $69.28 $5.3 Million - $5.94 Million	85,687 Added 73.31%	202,572 $13.6 Million
Q3 2023 Nov 13, 2023	BUY	$64.85 - $71.7 $148,571 - $164,264	2,291 Added 2.0%	116,885 $7.92 Million
Q2 2023 Aug 11, 2023	BUY	$69.91 - $75.81 $5.1 Million - $5.53 Million	72,934 Added 175.07%	114,594 $8.2 Million
Q1 2023 May 15, 2023	SELL	$63.15 - $71.6 $1.6 Million - $1.82 Million	-25,355 Reduced 37.83%	41,660 $2.89 Million

Q4 2022 Feb 14, 2023	SELL	$54.21 - $70.44 $530,065 - $688,762	-9,778 Reduced 12.73%	67,015 $4.54 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $2.24 Million - $5.73 Million	42,221 Added 122.12%	76,793 $4.21 Million
Q2 2022 Aug 15, 2022	BUY	$59.26 - $71.14 $883,151 - $1.06 Million	14,903 Added 75.77%	34,572 $2.28 Million
Q1 2022 May 16, 2022	SELL	$55.72 - $67.12 $918,377 - $1.11 Million	-16,482 Reduced 45.59%	19,669 $1.31 Million
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $16,854 - $19,914	312 Added 0.87%	36,151 $2.11 Million
Q3 2021 Nov 15, 2021	SELL	$55.56 - $60.79 $46,170 - $50,516	-831 Reduced 2.27%	35,839 $2.15 Million
Q2 2021 Aug 16, 2021	SELL	$48.42 - $60.18 $62,510 - $77,692	-1,291 Reduced 3.4%	36,670 $2.2 Million
Q1 2021 May 14, 2021	BUY	$47.16 - $54.44 $501,074 - $578,425	10,625 Added 38.87%	37,961 $1.89 Million
Q4 2020 Feb 16, 2021	BUY	$48.52 - $58.02 $14,992 - $17,928	309 Added 1.14%	27,336 $1.37 Million
Q3 2020 Nov 13, 2020	SELL	$53.07 - $61.1 $372,604 - $428,983	-7,021 Reduced 20.62%	27,027 $1.48 Million
Q2 2020 Aug 14, 2020	SELL	$43.1 - $55.31 $807,694 - $1.04 Million	-18,740 Reduced 35.5%	34,048 $1.8 Million
Q1 2020 May 15, 2020	BUY	$37.79 - $51.33 $240,004 - $325,996	6,351 Added 13.68%	52,788 $2.36 Million
Q4 2019 Feb 18, 2020	SELL	$42.46 - $50.46 $11,082 - $13,170	-261 Reduced 0.56%	46,437 $2.32 Million
Q3 2019 Nov 14, 2019	BUY	$40.12 - $45.47 $1.87 Million - $2.12 Million	46,698 New	46,698 $2.08 Million
Q4 2017 Feb 14, 2018	SELL	$32.09 - $34.78 $542,321 - $587,782	-16,900 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$28.96 - $34.0 $489,424 - $574,600	16,900	16,900 $573,000

Others Institutions Holding AZN

# of Institutions

1,269

Shares Held

483M

Call Options Held

5.99M

Put Options Held

5.22M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $244B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capital International, Inc. with notifications on news.

Account

Capital International, Inc. Astrazeneca PLC Transaction History